Apyx Medical (APYX) FCF Margin (2011 - 2026)
Apyx Medical's (APYX) quarterly FCF Margin came in at 25.61% in Q2 2026, down 1244.0% on a YoY basis from 2.24% in Q2 2025, and down 406.17% quarter-over-quarter from 5.06% in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) FCF Margin (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported FCF Margin for 16 consecutive years, with 25.61% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 1244.0% year-over-year to 25.61%; the trailing twelve-month figure through Jun 2026 stood at 18.91% (up 265.0% YoY), and the FY2025 full-year result was 17.25%, up 2177.0% from the prior year.
- FCF Margin retreated to 25.61% in Q2 2026 per APYX's latest filing, from 5.06% in the prior quarter.
- Across five years, FCF Margin topped out at 29.41% in Q3 2023 and bottomed at 62.24% in Q1 2024.
- Historically, FCF Margin has averaged 27.64% across 5 years, with a median of 28.55% in 2025.
- The sharpest annual moves came in 2023 and 2024: FCF Margin surged 9028 bps in 2023, then tumbled 6939 bps in 2024.
- Over 5 years, FCF Margin stood at 37.05% in 2022, then jumped by 58 bps to 15.72% in 2023, then tumbled by 42 bps to 22.37% in 2024, then surged by 35 bps to 14.64% in 2025, then sank by 75 bps to 25.61% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 25.61%, 5.06%, and 14.64% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Apyx Medical | 125.85 Mn | 98.23 Mn | 8.87 Mn | -25.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.61% |
| Mar 31, 2026 | -5.06% |
| Dec 31, 2025 | -14.64% |
| Sep 30, 2025 | -31.49% |
| Jun 30, 2025 | -13.17% |
| Mar 31, 2025 | -8.03% |
| Dec 31, 2024 | -22.37% |
| Sep 30, 2024 | -39.98% |
| Jun 30, 2024 | -38.01% |
| Mar 31, 2024 | -62.24% |
| Dec 31, 2023 | -15.72% |
| Sep 30, 2023 | 29.41% |
| Jun 30, 2023 | -36.91% |
| Mar 31, 2023 | -16.40% |
| Dec 31, 2022 | -37.05% |
| Sep 30, 2022 | -60.87% |
| Jun 30, 2022 | -60.95% |
| Mar 31, 2022 | -38.40% |
| Dec 31, 2021 | -0.70% |
| Sep 30, 2021 | -31.91% |